Sun Ophthalmics
Manufacturing · Florida, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
PO Box 2051, Oviedo, Florida, 32765, Uni...Phone Number
(609) 720-9200Website
www.sunophthalmics.comRevenue
$6.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Sun Ophthalmics
Sun Pharma is the fourth largest specialty generic pharmaceutical company globally, with revenues of $5.4 billion and over 41,000 employees. The company is a prominent player in the U.S. generics market, holding the second position in prescriptions for dermatology, while also focusing on expanding its presence in specialty branded markets like ophthalmology and oncology. Sun Pharma's U.S. operations account for 30% of its global revenue, supported by various manufacturing and R&D facilities across the country. The company is committed to providing high-quality, affordable medicines to healthcare professionals and patients in more than 100 countries.Explore more
Sun Ophthalmics Org Chart
JC
Account Manager, Ophthalmic
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sun Ophthalmics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Sun Ophthalmics had a recent Job posting/layoffs
Check if Sun Ophthalmics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Sun Ophthalmics launches new products
Check out if Sun Ophthalmics is spiking on competitors!
Funding: Get notified immidiatlly once Sun Ophthalmics has new funding data
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Sun Ophthalmics
Earning: See what the market has to say on Sun Ophthalmics recently announced quarterly report
Sun Ophthalmics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Sun Ophthalmics as Masked Content
Find 3 more new buyers
Compare Similar Companies to Sun Ophthalmics
Compare insights from companies similar to Sun Ophthalmics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Sun Ophthalmics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sun Ophthalmics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sun Ophthalmics.
Sun Ophthalmics Tech Stack
A closer look at the technologies used by Sun Ophthalmics
Sun Ophthalmics News & Media
Sun Pharma Introduces Access Program for Patients Prescribed XELPROS in the U.S.
PRINCETON, N.J.--(BUSINESS WIRE)--#glaucoma--Sun Pharma Introduces Access Program for Patients Prescribed XELPROS in the U.S.Sun Pharma and SPARC Announce US FDA Approval of XELPROS™ to Treat Open-angle Glaucoma or Ocular Hypertension
MUMBAI, India & PRINCETON, N.J.--(BUSINESS WIRE)--#BAK--Sun Pharma’s XELPROS™ (latanoprost ophthalmic emulsion) 0.005% approved by the U.S. FDASun Pharma Announces U.S. FDA Approval of CEQUA™ to Treat Dry Eye Disease
MUMBAI, India & PRINCETON, N.J.--(BUSINESS WIRE)--#Cequa--Sun Pharma announces U.S. FDA approval of CEQUA™ (cyclosporine ophthalmic solution) 0.09%, to treat Dry Eye Disease
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Sun Ophthalmics
Sign Up For FreeTo access detailed company insights
Sun Pharma is the fourth largest specialty generic pharmaceutical company globally, with revenues of $5.4 billion and over 41,000 employees. The company is a prominent player in the U.S. generics market, holding the second position in prescriptions for dermatology, while also focusing on expanding its presence in specialty branded markets like opht... Read More
